Phenotypic detection of resistance mechanisms in gram-positive bacteria

被引:12
作者
Isabel Morosini, Maria [1 ]
Cercenado, Emilia [2 ]
Ardanuy, Carmen [3 ]
Torres, Carmen [4 ]
机构
[1] Hosp Univ Ramon y Cajal, Serv Microbiol, Madrid, Spain
[2] Hosp Gen Univ Gregorio Maranon, Serv Microbiol, Madrid, Spain
[3] Hosp Univ Bellvitge, Serv Microbiol, Barcelona, Spain
[4] Univ La Rioja, Area Bioquim & Biol Mol, Logrono, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2012年 / 30卷 / 06期
关键词
Staphylococcus; Enterococcus; Streptococcus pneumoniae; Antibiogram; Resistance phenotypes; INDUCIBLE CLINDAMYCIN RESISTANCE; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; TESTING SUSCEPTIBILITY; CLINICAL IMPLICATIONS; ENTEROCOCCUS-FAECIUM; MUPIROCIN; OXACILLIN;
D O I
10.1016/j.eimc.2011.09.009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antimicrobial resistance mechanisms among clinically relevant gram-positive microorganisms can be demonstrated using phenotypic tests that enable the interpretation of underlying mechanisms responsible for the in vitro resistance. The reporting of these mechanisms, either inferred or demonstrated, helps in the adjustment of clinical treatments and the epidemiological follow up of resistance traits. In the present work, phenotypic tests for detection of antimicrobial resistance mechanisms involving the most frequent antimicrobial families used against Staphylococcus spp., Enterococcus spp. and Streptococcus pneumoniae are analysed. In the case of Staphylococcus, phenotypic tests to reveal the mechanisms of resistance against beta-lactams, macrolides, lincosamides and streptogramin B (MLSB), as well as intermediate susceptibility to glycopeptides, resistance to aminoglycosides, mupirocin and linezolid are reviewed. Tests to detect glycopeptide resistance and high-level aminoglycoside resistance among enterococci are analysed. Detection of penicillin resistance, as well as diminished susceptibility to third generation cephalosporins, together with diminished susceptibility or even resistance to fluoroquinolones is also detailed. (c) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 31 条
[1]   Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase [J].
Arias, Cesar A. ;
Vallejo, Martha ;
Reyes, Jinnethe ;
Panesso, Diana ;
Moreno, Jaime ;
Castaneda, Elizabeth ;
Villegas, Maria V. ;
Murray, Barbara E. ;
Quinn, John P. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) :892-896
[2]   DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy [J].
Bongiorno, Dafne ;
Campanile, Floriana ;
Mongelli, Gino ;
Baldi, Maria Teresa ;
Provenzani, Rosamaria ;
Reali, Silvia ;
Lo Russo, Carolina ;
Santagati, Maria ;
Stefani, Stefania .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (11) :2336-2340
[3]   Enterococci resistant to glycopeptides [J].
Cattoir, Vincent ;
Leclercq, Roland .
M S-MEDECINE SCIENCES, 2010, 26 (11) :936-942
[4]  
Cercenado Emilia, 2010, Med Clin (Barc), V135 Suppl 3, P10, DOI 10.1016/S0025-7753(10)70035-X
[5]   Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications [J].
Chambers, HF .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :781-+
[6]   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[7]   Aminoglycoside resistance in enterococci [J].
Chow, JW .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (02) :586-589
[8]  
Clinical and Laboratory Standards Institute, 2011, M100S21 CLIN LAB STA, V31, pM100
[9]  
Croes S, 2010, CLIN MICROBIOL INFEC, V16, P979, DOI [10.1111/j.1469-0691.2010.02956.x, 10.1111/j.1469-0691.2009.02956.x]
[10]   Staphylococcus spp. in Spain:: present situation and evolution of antimicrobial resistance (1986-2006) [J].
Cuevas, Oscar ;
Cercenado, Emilia ;
Goyanes, Maria Jose ;
Vindel, Ana ;
Trincado, Pilar ;
Boquete, Teresa ;
Marin, Mercedes ;
Bouza, Emilio .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (05) :269-277